Vericel (VCEL) Competitors $37.10 -2.72 (-6.83%) Closing price 04:00 PM EasternExtended Trading$37.29 +0.19 (+0.51%) As of 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VCEL vs. VRNA, ROIV, ELAN, RVMD, LEGN, GRFS, TGTX, NUVL, LNTH, and AXSMShould you be buying Vericel stock or one of its competitors? The main competitors of Vericel include Verona Pharma PLC American Depositary Share (VRNA), Roivant Sciences (ROIV), Elanco Animal Health (ELAN), Revolution Medicines (RVMD), Legend Biotech (LEGN), Grifols (GRFS), TG Therapeutics (TGTX), Nuvalent (NUVL), Lantheus (LNTH), and Axsome Therapeutics (AXSM). These companies are all part of the "pharmaceutical products" industry. Vericel vs. Its Competitors Verona Pharma PLC American Depositary Share Roivant Sciences Elanco Animal Health Revolution Medicines Legend Biotech Grifols TG Therapeutics Nuvalent Lantheus Axsome Therapeutics Vericel (NASDAQ:VCEL) and Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation. Is VCEL or VRNA more profitable? Vericel has a net margin of 1.25% compared to Verona Pharma PLC American Depositary Share's net margin of 0.00%. Vericel's return on equity of 1.09% beat Verona Pharma PLC American Depositary Share's return on equity.Company Net Margins Return on Equity Return on Assets Vericel1.25% 1.09% 0.73% Verona Pharma PLC American Depositary Share N/A -69.65%-28.00% Which has preferable earnings and valuation, VCEL or VRNA? Vericel has higher revenue and earnings than Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVericel$237.22M7.87$10.36M$0.031,236.67Verona Pharma PLC American Depositary Share$42.28M210.95-$173.42M-$2.00-52.39 Do insiders and institutionals have more ownership in VCEL or VRNA? 85.9% of Verona Pharma PLC American Depositary Share shares are owned by institutional investors. 7.2% of Vericel shares are owned by insiders. Comparatively, 4.8% of Verona Pharma PLC American Depositary Share shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate VCEL or VRNA? Vericel currently has a consensus target price of $61.14, suggesting a potential upside of 64.81%. Verona Pharma PLC American Depositary Share has a consensus target price of $109.00, suggesting a potential upside of 4.04%. Given Vericel's stronger consensus rating and higher probable upside, equities research analysts clearly believe Vericel is more favorable than Verona Pharma PLC American Depositary Share.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vericel 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Verona Pharma PLC American Depositary Share 0 Sell rating(s) 11 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.15 Does the media refer more to VCEL or VRNA? In the previous week, Verona Pharma PLC American Depositary Share had 47 more articles in the media than Vericel. MarketBeat recorded 52 mentions for Verona Pharma PLC American Depositary Share and 5 mentions for Vericel. Vericel's average media sentiment score of 1.72 beat Verona Pharma PLC American Depositary Share's score of 0.51 indicating that Vericel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vericel 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Verona Pharma PLC American Depositary Share 22 Very Positive mention(s) 10 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, VCEL or VRNA? Vericel has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500. Comparatively, Verona Pharma PLC American Depositary Share has a beta of 0.24, meaning that its stock price is 76% less volatile than the S&P 500. SummaryVericel beats Verona Pharma PLC American Depositary Share on 12 of the 15 factors compared between the two stocks. Get Vericel News Delivered to You Automatically Sign up to receive the latest news and ratings for VCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCEL vs. The Competition Export to ExcelMetricVericelMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.00B$2.90B$5.53B$9.30BDividend YieldN/A2.43%4.59%4.03%P/E Ratio1,237.0820.2228.5619.60Price / Sales7.87182.78359.9473.66Price / Cash127.4341.0524.7327.56Price / Book6.277.618.155.55Net Income$10.36M-$55.11M$3.24B$257.73M7 Day Performance-7.64%7.56%2.03%0.95%1 Month Performance-13.05%11.47%8.29%10.68%1 Year Performance-25.58%0.88%28.40%15.67% Vericel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCELVericel3.7273 of 5 stars$37.10-6.8%$61.14+64.8%-17.9%$2.00B$237.22M1,237.08300News CoveragePositive NewsVRNAVerona Pharma PLC American Depositary Share2.2911 of 5 stars$91.20-0.4%$107.36+17.7%+402.7%$7.76B$42.28M-45.6030Analyst ForecastROIVRoivant Sciences2.7993 of 5 stars$10.74-2.3%$17.50+62.9%+2.5%$7.30B$29.05M-42.96860ELANElanco Animal Health1.4919 of 5 stars$14.48-1.1%$15.33+5.9%+7.7%$7.19B$4.44B19.579,000RVMDRevolution Medicines4.6056 of 5 stars$36.67-3.2%$67.58+84.3%-15.0%$6.83B$11.58M-9.17250Analyst ForecastGap UpLEGNLegend Biotech3.3711 of 5 stars$35.87+0.6%$72.60+102.4%-27.5%$6.59B$728.30M-60.802,609GRFSGrifols3.8703 of 5 stars$8.87-2.3%$10.30+16.1%+17.7%$6.10B$7.81B7.5823,822News CoverageGap UpTGTXTG Therapeutics3.5319 of 5 stars$35.98-2.0%$40.80+13.4%+83.7%$5.71B$329M149.92290Positive NewsNUVLNuvalent3.3156 of 5 stars$77.93-3.2%$119.60+53.5%+7.6%$5.60BN/A-17.7540LNTHLantheus4.539 of 5 stars$79.19-1.5%$130.50+64.8%-32.7%$5.48B$1.53B22.50700Positive NewsAXSMAxsome Therapeutics4.6947 of 5 stars$107.50+2.0%$172.33+60.3%+35.6%$5.29B$385.69M-18.63380Positive NewsAnalyst Revision Related Companies and Tools Related Companies VRNA Competitors ROIV Competitors ELAN Competitors RVMD Competitors LEGN Competitors GRFS Competitors TGTX Competitors NUVL Competitors LNTH Competitors AXSM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCEL) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vericel Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Vericel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VCEL Stock Alerts